Safety of Arthritis Drugs, Day 2, Part 4

The Food and Drug Administration’s Arthritis and Drug Safety and Risk Management Advisory Committees continued discussions in their joint meeting on… read more

The Food and Drug Administration’s Arthritis and Drug Safety and Risk Management Advisory Committees continued discussions in their joint meeting on possible safety of risks of “COX-2” inhibitors such as Bextra, Celebrex, and Vioxx. Participants suggested other studies that are needed to insure long-term drug safety.

The function of the advisory committees is to provide advice and recommendations to the FDA on regulatory issues. close

Report Video Issue

People in this video

  • Steven Abramson Chair New York University Medical School->Rheumatology
  • Joan Bathon Professor Johns Hopkins University School of Medicine
More People

Hosting Organization

More Videos From

Safety of Arthritis Drugs, Day 2,

More Videos
More information about

Safety of Arthritis Drugs, Day 2, Part 4

263 Views
Program ID:
185588-4
Category:
Public Affairs Event
Format:
Forum
Location:
Gaithersburg, Maryland, United States
First Aired:
Feb 24, 2005 | 3:36pm EST | C-SPAN 2

Airing Details

  • Feb 24, 2005 | 3:36pm EST | C-SPAN 2
Purchase a Download

Safety of Arthritis Drugs, Day 2, Part 4

  • MP3 audio - Standard
    Price:
    $0.99